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ABSTRACT: Pasteurella multocida is an important veterinary pathogen that causes a range of animal
diseases, including fowl cholera, hemorrhagic septicemia in cattle and atrophic rhinitis in swine. P. multocida
is generally recognized as a secondary invader contributing substantially to respiratory diseases in pigs by
aggravation of lung lesions. Five capsule serogroups are routinely identified in P. multocida (A, B, D, E, and
F) and each is generally associated with, but not completely restricted, to a specific host. A total of 16  isolates
of Pasteurella multocida capsular genotype A and two isolates capsular genotype D were characterized for
their susceptibilities to 10 antibiotics and the presence of four genes for virulence factors associated to adherence.
The use of PCR showed that colonization factors (ptfA), sialidases (nanH) and outer membrane proteins
(ompH) occurred in  100% porcine strains, while nanB as a further colonization-related gene was detected in
22% of isolates. The 94% of the isolates showed multiple-drug resistance. It was observed that 100% were
resistant to amoxicillin and spectinomicin. The resistance profiles suggested that cephalosporins and
sulphametozaxole were the drugs most likely to be active against P. multocida in vitro.
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Resistencia antimicrobiana y genes asociados a la interacción hospedero-microorganismo en
aislados de Pasteurella multocida de origen porcino de la región occidental de Cuba
RESUMEN: Pasteurella multocida es un patógeno de amplia distribución mundial,  responsable de diversos
procesos clínicos en varias especies de animales, produce el cólera aviar en aves, septicemia hemorrágica en
bovinos y la rinitis atrófica en cerdos. En esta especie animal P.multocida se considera, además  como un patógeno
secundario que contribuye sustancialmente a los procesos clínicos respiratorios, agravando las lesiones pulmonares.
Existen 5 serogrupos capsulares en P. multocida (A, B, D, E, and F) y cada uno es generalmente asociado, pero
no completamente restringido a un hospedero específico. En este estudio se realizó la caracterización de la
resistencia antimicrobiana frente a 10 antibióticos y la detección de cuatro genes asociados a la virulencia en 16
aislados de P. multocida tipo capsular A y 2 del tipo capsular D, todos procedentes de cerdos. Los ensayos de
PCR evidenciaron la presencia  de factores de colonización (ptfA), sialidasa (nanH) y la proteína de membrana
externa ompH en 100% de los aislados, mientras el gen nanB asociado a la colonización solamente se detectó
en 22% de los aislados. El 94% de los aislados mostraron multirresistencia  a los antimicrobianos evaluados, el
100% fueron resistentes a amoxicillin y spectinomicin. Los perfiles de resistencia detectados señalan que las
cephalosporina y sulphametozaxole fueron las drogas más activas contra P. multocida in vitro.
Palabras clave: P.multocida, factor virulencia, PCR, susceptibilidad antimicrobial.
INTRODUCTION
Pasteurella multocida is a worldwide-distributed
pathogen responsible for a broad range of diseases in
livestock (hemorrhagic septicemia, shipping fever),
poultry (fowl cholera), wildlife (avian cholera) and
laboratory rabbits (snuffles) (1). P. multocida is the type
species of the genus including the three subspecies;
P. multocida subsp. multocida, P. multocida subsp.
gallicida and P. multocida subsp. Septic (2,3). This
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bacterium is a major pathogen of pigs, being involved
in a number of different disease conditions. The main
diseases associated with this organism are progressive
atrophic rhinitis and pneumonic pasteurellosis, one of
the most common and widespread diseases of intensively
housed pigs and also playing a role to increasing the
severity of primary lung lesions in pigs (4, 5).
P. multocida shows a high antigenic variability and
a wide host spectrum, as well as different courses of
infection which also imply enormous difficulties in
producing vaccines (6). Strains of P. multocida are
grouped into five capsular serogroups (serogroups A,
B, D, E, and F) and are further classified into 16 somatic
serotypes (serotypes 1 to 16), which are primarily based
on lipopolysaccharide antigens (7). The recognized
virulence factors of this organism that have been
identified to date are the capsule and lipopolysaccharide
(1,7). Other key factors also include diverse adhesins,
toxins, siderophores, sialidases and outer membrane
proteins (6,8,9).
Although antimicrobial therapy is a widely available
tool for the prevention and control of clinical infections
(10,11), the antibiotic resistance in pathogenic bacteria
from food-producing animals and environmental sources
is recognized as a global problem for public health (10,
12). Numerous previous studies have reported that the
imprudent use of antimicrobials bears a high risk for
the selection of resistant bacteria and promotes the
spread of resistance genes located on plasmids,
integrons and transposons thought the process of
horizontal transfer gene (13).
The prevalence of serotypes and pathotypes of P.
multocida can vary considerably according to the
geographical distribution and over time in a given region.
The use of control methods such as antimicrobial or
autogenous vaccines requires studies in each
geographical area (13). These studies are useful for
identifying the presence of pathogenic strains, which
are predominant , and  establishing the persistence of
these strains over time. A successful approach for the
identification of virulent strains is the differentiation of
capsular serotypes using specific antisera or the
corresponding cps types by genotypic assessment,
with the subsequent detection of virulence associated
factors. To date, in Cuba there are no studies concerning
the presence of virulence associated genes known so
far in porcine P. multocida strains. The aim of this study
was thus to research the presence of so far known
virulence associated genes in P. multocida isolates and
to evaluate the antibiotic susceptibility.
MATERIALS AND METHODS
The selected isolates of P. multocida (nP=18) were
recovered from 2004 (n=10), 2010 (n=3) and 2011 (n=5)
in the course of routine diagnostic procedures from
diseased pigs lung. Pigs included in the study were
classified into two production stages: post-weaning (4-
10 weeks) and transition (10-18 weeks) belonging to
five farrow-to-finish farms in several geographic areas
within the western region. Bacteria were cultured on
Columbia agar plus 5% sheep blood plates. All the
isolates were identified by standard methods as api
NE (biomeriuex), not grown in Mac Conkey agar. After
identification, bacteria were lyophilized and stored at
4oC until they were used.
Identification of P. multocida isolates was confirmed
using species-specific PCR with primers KMT1T7 and
KMT1SP6, as previously described (14).  The capsular
types of the isolates were determined by capsule PCR
typing with the capsule-specific primer pairs (primers
specific for capA, capD and capB) described by
Townsend et al. (15). The primer sequences used in
the capsule PCR typing assay for P. multocida are listed
in Table 1. Four pairs of oligonucleotide primers were
used for the detection of virulence genes (VG) ompH,
ptfA, nanH and nanB (6). Details of all oligonucleotide
primers used and PCR conditions applied for the
detection are listed in Table#1. Each isolate was tested
under the same conditions twice. All oligonucleotides
were custom synthesized (CIGB, Cuba).
The bacterial lysates used as templates for  PCR
were prepared as follows. A loopful of a bacteria colony
from a fresh overnight culture on a Columbia agar plate
was resuspended homogeneously in 50 µL of sterile
water and the mixture was boiled at 100°C for 5 min
and frozen at 20oC for 10 min to release the DNA and
centrifuged to 3000g (14). A 5 µL volume of the
supernatant was used as a template for each 25 µL
PCR mixture containing 20 pmol of each primer,
0,4 mM of dNTPs, 1x PCR buffer, 3 mM MgCl2 and 1 U
Taq DNA polymerase (Invitrogen).
The amplified DNA was visualized in 2% agarose
gels in TBE buffer (90 mM Tris, 90 mM borate, 2.5 mM
EDTA [pH 8]) for 1h at a constant voltage of 125V.
Amplified products were stained with ethidium bromide
(0.5µg/µL) and detected by UV transillumination. The
50pb ladder (Promega) was used as standard.
Antimicrobial susceptibility was determined by disk
diffusion methods by following CLSI guidelines (16).
The antimicrobial agents used and their respective
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concentration were as follows: amoxicillin (30µg);
neomycin (30µg); erythromycin (15µg); tetracycline
(30µg); trimethoprim/sulphamethoxazole (25µg),
spectinomycin (25µg); amikacin (30µg),
chloramphenicol (30µg), nalidixic acid (30µg) and
cepholetin (30µg) . They were supplied by the  Oxoid.
The inoculums were prepared from a 24 hour Columbia
blood agar plate by suspending several colonies in 5
mL of saline solution and were adjusted to 0.5
McFarland standards. One hundred microliters of the
adjusted inoculums were deposited on the surface agar
Muller Hinton plate and further incubated at 37oC for 24
h. For the antimicrobials, the breakpoint values were
taken from the CLSI guidelines (16)
RESULTS AND DISCUSSION
The P. multocida isolates were researched for kmt,
the presence of three capsule biosynthesis genes and
four virulence associated genes by PCR analyses.
Pasteurellosis is one of the most common diseases of
pigs worldwide (17,18). It is remarkable that P.
multocida, one of the first agents specifically identified
in pneumonic swine lung, continued throughout the past
over 100 years as a major agent in porcine pneumonia,
often mixed with viral agents and continues today
without any evidence of being diminished (19). In this
study the isolates of P. multocida were from post-
weaning pigs and transition with lesions in the lungs
and clinical signs of pneumonia. Xibiao et al 2009
detected strains of P. multocida throughout the year
without seasonal variation from growing pigs 60 to 110
days old (20). A study in tonsils using high throughput
bar-coded 454-FLX pyrosequencing defined the core
microbiome dominated by Pasteurellaceae, in theses
structures of pig that are constantly exposed to both
ingested and inhaled microorganisms including both
bacteria and viruses (21).
The whole 18 isolates were confirmed as P.
multocida based on the kmt species specific gene PCR
amplification product. The identification of P. multocida
depends on standard culture methods and serotyping.
These methods are labor intensive and results can be
inconclusive. In recent years, genotypic methods of
bacterial identification have proved beneficial in
overcoming some limitations of traditional phenotypic
procedures. For ease and rapidity, PCR was performed
directly from single colonies, grown on agar plates in
primary cultures from contaminated sites on the animal,
such as tonsil and lung (14). A pipette tip was lightly
touched onto a colony, and this sample was then
resuspended in PCR amplification mixture. The primer
pair KMT1SP6-KMT1T7 amplif ied a product of
approximately 460 bp from all isolates of P. multocida.
P. multocida in pigs can cause two different clinical
presentations: the atrophic rhinitis and pneumonia as
a secondary invader. P. multocida plays a secondary
in combination with other viral or bacterial infections
contributing substantially to respiratory diseases in pigs
TABLE 1. Sequence and PCR conditions applied for the detection of virulence associated genes in P. multocida 
strains./ Secuencia y condiciones de la reacción en cadena de la polimerasa utilizadas para la detección de genes 
asociados  a la virulencia en cepas de P. multocida. 
 
PCR conditions (°C/s) Gene Primer sequence (5?-3?) PCR 
product 
size(bp) 
Desnaturation Annealing Elongation 
atccgctatttacccagtgg KMT1SP6 
KMT1T7 gctgtaaacgaactcgcca 
460pb 94/30 57/40 72/60 
tgccaaaatcgcagtcag Capsular 
Type A ttgccatcattgtcagtg 
1044pb 
ttacaaaagaaagactaggagccc Capsular 
Type D catctacccactcaaccatatcag 
657pb 
catttatccaagctccacc Capsular 
Type B gcccgagagtttcaatcc 
760pb 
94/30 55/40 72/60 
cgcgtatgaaggtttaggt ompH 
tttagattgtgcgtagtcaac 
418pb 94/30 58/30 72/60 
tgtggaattcagcattttagtgtgtc ptfA 
tcatgaattcttatgcgcaaaatcctgctgg 
468pb 94/30 55/30 72 
gaatatttgggcggcaaca nanH 
ttctcgccctgtcatcact 
340pb 94/30 56/30 72/30 
agtgtccgggaatagtggtg nanB 
ccgttgttcacaacgaacc 
537pb 94/30 58/30 72/60 
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by aggravation of lung lesions. These two clinical
presentations have been predominantly linked to the
capsule antigen D and capsule antigen A respectively
(18). In this study, sixteenth isolates belong to A capsular
serogroup and two isolates correspond to D capsular
serogroup. The capsular PCR assay also provides a
rapid and highly specific alternative to conventional
capsular serotyping, there are currently only two
laboratories worldwide that make and maintain the
antisera required for capsular typing (15).
The atrophic rhinitis is less frequent as reported data
from different countries, in the United States (17),
England and Wales (18), thus the prevalence of strains
of capsular serogroup D is lower than that of serogroup
A. However, in Australian (22) and Asia (20,23), the
prevalence of strains of capsular serogroup D is higher
than that of serogroup A although atrophic rhinitis is
seldom reported in these countries (20). There was a
high numerous of isolates capsular type A, the two
isolates capsular type D corresponding to 2011. Our
findings suggest that the capsule type A and D isolates
were to the same extent associated with pneumonic
lesions in swine, that have been predominantly linked
to the capsule antigen A in the past (6). None of the
isolates amplified the fragment with capB-specific
primers corresponding to the capsule biosynthetic loci
of B serogroup. The strains of serogroup B have
occasionally been implicated as a cause of a
pneumonic disease in swine in China (20) or a
septicemic disease in India, Sri Lanka and Vietnam
(15,19). P. multocida is rarely considered the primary
agent, but rather constitutes a part of the porcine
respiratory disease complex (PRDC). However the
findings of pericarditis and positive cultivation of P.
multocida from the pericardial sac indicate that
bronchopneumonia associated with P. multocida is a
part of a more complex disease pattern affecting other
organ systems in addition to the respiratory tract (24).
The ability to cause pathogenesis in such a wide
range of host species suggests that P. multocida must
have an armamentarium of adhesins to allow tissue
colonization. However, the ways in which these
molecules interact with the host have not been
elucidated (25). All the isolates amplified the fragments
of 418pb and 468pb corresponding to ompH and ptfA
genes respectively (Figure 1). Escribe texto o la
dirección de un sitio web, o bien, traduce un
documento.Cancelatraducción del español al inglésThe
outer membrane proteins (OMPs, Outer Membrane
Proteins) are present in many Gram-negative bacteria,
developing a role in pathogen-host interactions involved
in nonspecific adhesion, immunomodulation, cytokine
secretion, cytoskeletal changes and chemotaxis
neutrófilos (26). The DNA sequence analyses of ptfA
genes from various P. multocida strains showed a high
degree of variation that could limit the potency of a
vaccine based on this fimbrial antigen to cause a
heterologous, capsule- and serotype independent
protection considerably (6).
 50MW ompH  ptfA  nanH    nanB 
 
418pb 
555pb 
360pb 
488pb 
Sialidase is the only extracellular glycolytic enzyme
produced by P. multocida, suggesting that this enzyme
probably plays a major role in the ability of P. multocida
to colonize animals.  Many P. multocida isolates possess
two sialidase genes (nanH and nanB) that encode
enzymes with different substrate specificities (27).  Of
the sialidase-encoding genes studied, nanH (100%) was
more frequent than nanB (22%), this last one only was
present in A type isolate (n=4) while nanH in A and D
types isolates. Tang et al (20) also found that of the
sialidase-encoding genes studied, nanH (97.0%) was
more prevalent than nanB (81.5%), in contrast  Ewers et
al. (6) found that of the sialidase-encoding genes, nanB
was present in  100% of the P. multocida strains tested
while nanH in 98.1%. These genes are part of the operon
encoding two sialidases whose function is to release
sialic acid from different host compounds, for example,
to glycoproteins and glycolipids, thus, used as carbon
source, also involved in virulence as they discover
receptor cells of the mucous membranes of the host
and / or reduce their defenses (27).
FIGURE 1. Amplified DNA from four virulence genes of P.
multocida associated to virulence  ompH, fim4, nanH, nanB
(Lane1 50pb ladder, lane 2 fragment (418pb) ompH, lane 3
fragment (461 pb) ptfA, lane 4 fragment (340pb) nanH, and
lane 5 fragment (537pb) nanB./ ADN amplificado a partir
de cuatro genes de P. multocida asociados a la virulencia
ompH, ptfA, nanH, nanB (línea 1 marcador de 50pb, lí-
nea 2 fragmento (418pb) ompH línea 3 fragment (461 pb)
ptfA, línea 4 fragment (340pb) nanH, línea 5 fragment
(537pb) nanB.
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About the metabolism of the sialic acids, a
structurally diverse group of nine-carbon keto sugars,
has hypothesized that the interplay between its
metabolism and the host-microbe interaction is a
unifying theme for understanding diseases caused by
a wide range of invasive pathogens or commensals.
Other pathogens, such as Neisseria gonorrhoeae and
Haemophilus spp, do not synthesize sialic acid but
scavenge host-derived (environmental) sialic acids for
cell surface decoration (modification) involving
endogenous sialyltransferases. In addition to de novo
synthesis or scavenging of sialic acid, some pathogens
may also catabolize environmental sialic acid for nutrition
(carbon, nitrogen and energy) or as a source of amino
sugars for cell wall biosynthesis (28,29). In P. multocida
, nanH or nanB genes could confer the bacterium not
only growth benefit but also the property to adhere  and
invade host cells by unmasking host receptors (30).
The nanH sialidase-deficient mutants of P. multocida
have a reduced abil ity to replicate with host
glycoconjugants as carbon sources (31).
Productive infection by bacterial pathogens relies
on the expression of virulence factors that have wide
ranging functions like competence, adherence, capsule
synthesis and export, evading host immune responses.
One of the difficulties associated with the development
of a heterologous vaccine for P. multocida is that strains
of this organism exhibit extensive genetic heterogeneity
within and between serotypes (32). Thus, identification
of an antigenic factor or DNA region conserved across
capsular types or pathogenic strains irrespective of
geographic origin may help to obviate this problem. The
presence of the VF genes examined, which encode
colonization factors (ptfA), sialidases (nanH), and outer
membrane proteins (ompH), was equally in both (A and
D) capsular type. These distribution patterns would
support some lines of evidence suggesting the factors
involved in adhesion may potentially serve as vaccine
candidates that can elicit homologous protective
immunity against all serogroup of P. multocida (32).
Eigteen  isolates of P. multocida recovered from
diseased swine were tested for resistance to 10
antibiotics. The prevalence of resistance to conventional
antibiotics, including amoxicillin, spectinomicin and
tetracycline among the P. multocida isolates was found
to be in excess of 100-88% for each antibiotic (Figure
2). The 25% of isolates from 2004 and 88% of isolates
from 2010-2011 showed a progressive increase of
resistance to tetracycline. Therefore, preventive and
therapeutic effects on porcine P. multocida strains
should no longer be expected from these antibiotics.
Susceptibility of P. multocida isolates to eritromicin,
neomicin, nalidixic acid and amikacin was variable. Of
the P. multocida isolates tested corresponding to 2004,
all of them were inhibited effectively by cloranphenicol;
however the isolates corresponding to 2010-2011
showed a slight increase in resistance. In the present
study, nalidixic acid, neomicine and amikacin exhibited
moderate activity against all strains tested. Therefore,
these antimicrobials could be still considered as primary
therapeutic agents for the empiric treatment of P.
multocida infections.
It was observed that 94% of isolates were
multiresistant (resistant to from 3 to 10 antibiotics).
Most of the resistance genes to date encountered
among P. multocida isolates are associated with either
small plasmids or with conjugative and nonconjugative
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FIGURE 2. Resistance percentage distribution in Pasteurella multocida isolates from two
different years against to 10 antimicrobials./ Distribución del porcentaje de resistencia frente
a diez antimicrobianos en aislados de P. multocida  en dos períodos de tiempo diferentes.
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transposons (33,34). Alvaro et al (35) found coexistence
of multiple antimicrobial resistance plasmids in P.
multocida strains from Spain and explained the resistant
to tetracyclines and/or streptomycin as well as to
sulfonamides.
Our results about antibiotic susceptibility, like the
findings of Kehrenberg et al. (13) in France, Salmon et
al. (36) in North America and Yoshimura et al. (37) in
Japan, indicated that cephalosporin (cephaletin) was
one of the most active drug, however in our study
trimethoprim/sulphametoxazole were also an active
drug. The high proportion of strains susceptible to
sulphonamides (sulphathiazole) indicates that P.
multocida is mainly susceptible to this antimicrobial
agent. Bacteria respond to antibiotic stress with a
transcriptional reflex to counteract the assault on
essential processes such as cell wall synthesis,
translation, transcription and replication. The
transcriptional responses of P. multocida to different
antibiotics with known mode of actions were collected
to create a compendium of transcriptional profiles; the
trimethoprim caused a marked reduction in the
transcription of capsule genes, which correlated with a
concomitant reduction of the capsular layer on the
surface of P. multocida (38).
To the authors’ knowledge, this is the first extended
study of genetic diversity within a collection of P.
multocida isolates from pigs using molecular methods
including the amplification of virulence genes in Cuba.
This is the first report indicating the occurrence of at
least two capsular types A and D and the presence of
gene fragments  associated to the host-microbe
interaction among the P.multocida isolates tested. A
larger scale sampling of several pig farms from different
geographical regions of the country could enable us to
design a strategy to minimize the risk of exposure to
P. multocida.
Studies on antibiotic susceptibility and resistance
are very few and hence this study on in vitro
susceptibility test on P. multocida isolates would be
helpful in formulating control measures for P. multocida
infection in swine. Therefore it is important to evaluate
the efficacy of various antimicrobial drugs currently used
in swine and to determine patterns of antibiotic
sensitivity. The high prevalence of multiresistant strains
of P. multocida in pigs and the association of such
strains with serious disease strongly suggest that more
attention should be paid to the prudent use of
antimicrobials. The resistance development in isolates
is a continuous process in which novel resistance genes
may be acquired or developed under the selective
pressure imposed by the use of new drugs (19).
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